Firebrick Pharma Limited (FRE.AX)
AUD 0.07
(0.0%)
AUD 0.07
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 14.52 Thousand | 830.00 | 4124.00 | 422 Thousand | 508.97 Thousand | - |
| Cost of Revenue | 37.3 Thousand | - | - | 520.00 | 301.00 | 451.00 |
| Gross Profit | -22.78 Thousand | 830.00 | 4124.00 | 421.48 Thousand | 508.67 Thousand | -451.00 |
| Operating Expenses | -22.78 Thousand | 6.85 Million | 4.87 Million | 2.86 Million | 2 Million | 1.17 Million |
| Selling, General and Administrative Expenses | 473.91 Thousand | 2.76 Million | 829.31 Thousand | 1.72 Million | 378.97 Thousand | 116.36 Thousand |
| Research and Development Expenses | 1.9 Million | 4.09 Million | 2.21 Million | 1.13 Million | 1.62 Million | 1.05 Million |
| Other Expenses | - | 21.72 Thousand | 1.07 Million | - | - | - |
| Cost and Expenses | 3.94 Million | 6.86 Million | 4.87 Million | 2.86 Million | 2 Million | 1.17 Million |
| Operating Income | -944.05 Thousand | -6.86 Million | -3.79 Million | -2.86 Million | -2 Million | -1.17 Million |
| Interest Expense | 1007.00 | - | 4144.00 | - | - | - |
| Income Tax Expense | - | -21.72 Thousand | 1.08 Million | -422 Thousand | -508.97 Thousand | -444.97 Thousand |
| Earnings before Tax | -1.17 Million | -6.82 Million | -3.79 Million | -2.86 Million | -2 Million | -1.17 Million |
| Net Income | -1.17 Million | -6.8 Million | -3.79 Million | -2.43 Million | -1.49 Million | -725.25 Thousand |
| Earnings Per Share Basic | -0.01 | -0.04 | -0.02 | -0.01 | -0.01 | -0.00 |
| Earnings Per Share Diluted | -0.01 | -0.04 | -0.02 | -0.01 | -0.01 | -0.00 |
| Weighted Average Shares Outstanding | 179.02 Million | 170.09 Million | 168.84 Million | 168.84 Million | 168.84 Million | 168.84 Million |
| Weighted Average Shares Outstanding (Diluted) | 179.01 Million | 170.09 Million | 168.84 Million | 168.84 Million | 168.84 Million | 168.84 Million |
| Gross Margin | -1.57 | 1.00 | 1.00 | 1.00 | 1.00 | - |
| EBIT Margin | -74.69 | -8258.10 | -917.85 | -6.78 | -3.94 | - |
| Profit Margin | -80.97 | -8195.27 | -920.54 | -5.78 | -2.94 | - |
| EBITDA | -1.08 Million | -6.81 Million | -3.5 Million | -2.43 Million | -1.49 Million | -1.17 Million |
| Earnings Before Tax Margin | -65.01 | -8269.57 | -919.54 | -6.78 | -3.95 | - |
| Breakdown | 2024 Q4 | 2024 FY | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY |
|---|---|---|---|---|---|---|
| Revenue | 467.08 Thousand | 14.52 Thousand | 467.08 Thousand | 908.06 Thousand | 908.06 Thousand | 830.00 |
| Cost of Revenue | 18.65 Thousand | 870.9 Thousand | 18.65 Thousand | 3609.00 | - | - |
| Gross Profit | 448.43 Thousand | -856.38 Thousand | 448.43 Thousand | 904.45 Thousand | 908.06 Thousand | 830.00 |
| Operating Expenses | 521.41 Thousand | 3.07 Million | 521.41 Thousand | 907.07 Thousand | 1.36 Million | 6.85 Million |
| Selling, General and Administrative Expenses | 376.6 Thousand | - | 376.6 Thousand | 1.1 Million | 499.32 Thousand | - |
| Research and Development Expenses | 144.81 Thousand | - | 144.81 Thousand | 1.61 Million | 807.79 Thousand | - |
| Other Expenses | 919.66 Thousand | - | - | 1.81 Million | - | 21.72 Thousand |
| Cost and Expenses | 540.06 Thousand | 3.94 Million | 540.06 Thousand | 910.68 Thousand | 1.36 Million | 6.86 Million |
| Operating Income | -72.97 Thousand | -3.92 Million | -72.97 Thousand | -910.68 Thousand | -436.01 Thousand | -6.86 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | -36.95 Thousand | -2.73 Million | -36.95 Thousand | 1.00 | - | -21.72 Thousand |
| Earnings before Tax | -138.72 Thousand | -3.91 Million | -138.72 Thousand | -898.41 Thousand | -449.2 Thousand | -6.82 Million |
| Net Income | -138.72 Thousand | -1.17 Million | -138.72 Thousand | -898.41 Thousand | -449.2 Thousand | -6.8 Million |
| Earnings Per Share Basic | -0.00 | - | -0.00 | -0.01 | -0.00 | - |
| Earnings Per Share Diluted | -0.00 | - | -0.00 | -0.01 | -0.00 | - |
| Weighted Average Shares Outstanding | 181.81 Million | 179.01 Million | 181.81 Million | 176.36 Million | 176.36 Million | 170.09 Million |
| Weighted Average Shares Outstanding (Diluted) | 181.66 Million | 179.01 Million | 181.66 Million | 176.36 Million | 176.36 Million | 170.09 Million |
| Gross Margin | 0.96 | -58.97 | 0.96 | 1.00 | 1.00 | 1.00 |
| EBIT Margin | -0.23 | - | -0.23 | -1.00 | -0.48 | - |
| Profit Margin | -0.30 | -80.97 | -0.30 | -0.99 | -0.49 | -8195.27 |
| EBITDA | -108.14 Thousand | - | -108.14 Thousand | -907.07 Thousand | -434.2 Thousand | - |
| Earnings Before Tax Margin | -0.16 | -270.46 | -0.16 | -1.00 | -0.48 | -8269.57 |
6117
SUNI
6775
POS
STBA
CHEMPLASTS